SCHEDULE 13G/A: William Blair Investment Management Discloses 5.0% Stake in Twist Bioscience Corp
Beneficial Ownership Disclosure
William Blair Investment Management, LLC has disclosed a 5.0% beneficial ownership stake in Twist Bioscience Corp, holding 2,949,723 shares of common stock as of December 31, 2024.
Summary
- William Blair Investment Management, LLC reported beneficial ownership of 2,949,723 shares of Twist Bioscience Corp common stock.
- This ownership represents 5.0% of the total class of securities.
- The filing date for this Schedule 13G Amendment No. 1 is February 12, 2025, with the event date requiring the filing being December 31, 2024.
- William Blair Investment Management, LLC is classified as an Investment Adviser (IA) under SEC rules.
- The shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing the control of Twist Bioscience Corp.
Sentiment
Score: 6
Explanation: The disclosure of a significant 5.0% stake by a reputable investment management firm like William Blair is generally viewed as a positive signal of institutional confidence in the issuer, Twist Bioscience Corp. The filing explicitly states the shares are held in the ordinary course of business, indicating a passive, investment-oriented position.
Positives
- William Blair Investment Management, LLC, a reputable investment adviser, has taken a significant 5.0% stake in Twist Bioscience Corp, indicating potential institutional confidence in the company's prospects.
- The filing explicitly states the shares were acquired and are held in the ordinary course of business, suggesting a passive, long-term investment perspective rather than an activist intent.
Future Outlook
NA
Industry Context
This filing indicates continued institutional investor interest in the biotechnology and synthetic biology sectors, as a major investment management firm has taken a significant stake in Twist Bioscience Corp, a company operating in this space.
Stakeholder Impact
- Shareholders: May view the significant institutional investment as a positive sign of confidence, potentially influencing stock price positively due to increased institutional backing.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which required the filing of this statement (beneficial ownership threshold met). |
| 02/12/2025 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Twist Bioscience, William Blair Investment Management, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investment, biotechnology, synthetic biology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.